Patience C. Ogbozor
Director/Board Member presso KID CASTLE EDUCATIONAL CORPORATION
Profilo
Ms. Patience C.
Ogbozor is a President, Chief Executive Officer & Director at Cannabinoid Biosciences, Inc. She is on the Board of Directors at Opportunity Zone Capital LLC, GiveMePower Corp., Kid Castle Educational Corp., Video River Networks, Inc., Goldstein Franklin, Inc. and Cannabinoid Biosciences, Inc.
Posizioni attive di Patience C. Ogbozor
Società | Posizione | Inizio |
---|---|---|
KID CASTLE EDUCATIONAL CORPORATION | Director/Board Member | 23/10/2019 |
GIVEMEPOWER CORPORATION | Director/Board Member | 01/12/2019 |
VIDEO RIVER NETWORKS, INC. | Director/Board Member | 01/10/2019 |
Cannabinoid Biosciences, Inc.
Cannabinoid Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Cannabinoid Biosciences, Inc. engages in the discovery, development, and commercialization of cannabinoid, cannabidiol, endocannabinoids, phytocannabinoids, and synthetic cannabinoids. It seeks to commercialize its products through collaborations with pharmaceutical companies for the specific treatments of diseases and medical conditions. The company was founded in May 2014 and is headquartered in Torrance, CA. | Chief Executive Officer | 01/11/2018 |
Goldstein Franklin, Inc. | Director/Board Member | 01/06/2015 |
Opportunity Zone Capital LLC | Director/Board Member | 18/02/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
KID CASTLE EDUCATIONAL CORPORATION | Commercial Services |
GIVEMEPOWER CORPORATION | Technology Services |
VIDEO RIVER NETWORKS, INC. | Electronic Technology |
Aziende private | 3 |
---|---|
Cannabinoid Biosciences, Inc.
Cannabinoid Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Cannabinoid Biosciences, Inc. engages in the discovery, development, and commercialization of cannabinoid, cannabidiol, endocannabinoids, phytocannabinoids, and synthetic cannabinoids. It seeks to commercialize its products through collaborations with pharmaceutical companies for the specific treatments of diseases and medical conditions. The company was founded in May 2014 and is headquartered in Torrance, CA. | Health Technology |
Goldstein Franklin, Inc. | |
Opportunity Zone Capital LLC |
- Borsa valori
- Insiders
- Patience C. Ogbozor